The global occurrence of type 2 diabetes mellitus (a disease condition attributed to an increased level of glucose in the systemic circulation arising from insulin insensitivity, inaction, or both) is rapidly becoming a concerning healthcare issue due to its associated mortality, morbidity, and economic burden [1–3]. Here, INS is linked to diabetes mellitus.